--- title: "FDA approves Mounjaro to reduce heart risks in type 2 diabetes patients" description: "Most outlets reported the FDA's approval of Mounjaro to reduce cardiovascular risks in adults with type 2 diabetes. BOL News and ARY News (English) also mentioned the drug’s initial 2022 approval for blood sugar control, while ProPakistani focused primarily on the new heart risk reduction indication without referencing the earlier approval." url: https://harzaviya.com/stories/5334-fda-approves-mounjaro-to-protect-high-risk-diabetes-patients site: HarZaviya language: en --- # FDA approves Mounjaro to reduce heart risks in type 2 diabetes patients health · latest filing 29 Aug 2026, 4:58 PM PKT · 28–29 Aug 2026 · 4 articles from 4 outlets over 2 developments ## How it developed Newest development first. Each carries its own coverage and, where we have one, our summary of it. ### 29 Aug 2026 — FDA approves Mounjaro to reduce heart risks in type 2 diabetes patients (3 outlets) > Most outlets reported the FDA's approval of Mounjaro to reduce cardiovascular risks in adults with type 2 diabetes. BOL News and ARY News (English) also mentioned the drug’s initial 2022 approval for blood sugar control, while ProPakistani focused primarily on the new heart risk reduction indication without referencing the earlier approval. - **ProPakistani** — [FDA Approves Drug to Reduce Heart Attack Risk in People With Type 2 Diabetes](https://propakistani.pk/2026/08/29/fda-approves-drug-to-reduce-heart-attack-risk-in-people-with-type-2-diabetes/) · 29 Aug 2026, 4:58 PM PKT > The U.S. Food and Drug Administration (FDA) has approved Eli Lilly’s Mounjaro (tirzepatide) to reduce the risk of serious cardiovascular… Read More - **ARY News (English)** — [US approves Mounjaro to reduce cardiovascular risk](https://arynews.tv/us-approves-mounjaro-to-reduce-cardiovascular-risk) · 29 Aug 2026, 4:43 PM PKT · 81% identical wording to the newest filing > US FDA has approved ​diabetes drug Mounjaro to reduce the chances of heart ‌attack or stroke in adults with type 2 diabetes - **BOL News** — [FDA approves Mounjaro to protect high-risk diabetes patients from heart risks](https://www.bolnews.com/latest-news/fda-approves-mounjaro-to-protect-high-risk-diabetes-patients-from-heart-risks/) · 29 Aug 2026, 2:23 PM PKT · 78% identical wording to the newest filing > Mounjaro was first approved by the FDA in 2022 for improving blood sugar control in adults with type 2 diabetes. ### 28 Aug 2026 — US FDA approves Mounjaro to reduce cardiovascular risk (1 outlet) - **The News International** — [US FDA approves Mounjaro to reduce cardiovascular risk](https://www.thenews.com.pk/latest/1414007-us-fda-approves-mounjaro-to-reduce-cardiovascular-risk) · 28 Aug 2026, 6:08 PM PKT > The FDA has officially approved its diabetes drug Lilly’s Mounjaro to prevent a heart attack or stroke in adults with type 2 diabetes who are at high risk of cardiovascular events on Friday.Mounjaro is the primary drug that targets the GLP-1 protein and is also used for weight loss.... 4 articles from 4 outlets, 28–29 Aug 2026. Headlines and links belong to their outlets — HarZaviya links out and never copies article text. --- HarZaviya compares how Pakistani outlets cover the same story. It stores and shows each outlet's headline and a short excerpt, and links out — it never copies article text, and every headline belongs to the outlet that wrote it. It takes no stance on any outlet. Pages: [Top stories](https://harzaviya.com/) · [Latest headlines](https://harzaviya.com/feed) · [Archive](https://harzaviya.com/archive) · [Why](https://harzaviya.com/why) · [Sources](https://harzaviya.com/sources) · [Methodology](https://harzaviya.com/methodology) · [About](https://harzaviya.com/about) · [About the bot](https://harzaviya.com/about-bot) Trackers: [Gold prices](https://harzaviya.com/gold-prices) · [Fuel prices](https://harzaviya.com/fuel-prices) · [Stock exchange](https://harzaviya.com/stock-exchange) Any page on this site is available as markdown: send `Accept: text/markdown`, or add `.md` to the path.